New updates have been launched by the ACMD (Advisory Council on the Misuse of Drugs) in relation to reducing the barriers to research using compounds described by the third generation synthetic cannabinoid receptor agonists generic definition.
The ACMD (Advisory Council on the Advisory Council on the Misuse of Drugs) and MHRA (Medicines & Healthcare products
Regulatory Agency) has evaluated the risk of substance abuse and physical dependency of the medicine Sunosi (Solriamfetol). Sunosi is a once-daily prescription medicine used to improve wakefulness in adults with excessive daytime sleepiness due to obstructive sleep apnoea or narcolepsy.
Find out all you need to know and more in our article on the subject here!…
The Advisory Council on the Misuse of Drugs (ACMD) has been commissioned to provide impartial and independent scientific advice on the acceptable levels of constituent cannabinoids in cannabidiol (CBD) products (in other words, other than CBD itself) marketed as consumer products.
The commission does not extend to prescribed products/medicines. The ACMD invites all sections of society to provide written evidence with regards to this commission.
Can you help? Find out how you can help, along with contact information inside this article!…
The UK Government’s Advisory Council For The Misuse Of Drugs Committee is looking at barriers to research working group calls for written evidence about barriers to legitimate research for controlled drugs.
We all need to do our part to advance the knowledge, care pathways, treatment options and improvement for the statistical improvement on the chances for long term, successful, happy, healthy recovery.